Logo image of AFJK

AIMEI HEALTH TECHNOLOGY CO (AFJK) Stock Overview

USA - NASDAQ:AFJK - KYG013411098 - Common Stock

11.33 USD
-0.07 (-0.61%)
Last: 10/23/2025, 8:00:01 PM

AFJK Key Statistics, Chart & Performance

Key Statistics
Market Cap69.34M
Revenue(TTM)N/A
Net Income(TTM)1.79M
Shares6.12M
Float4.06M
52 Week High11.49
52 Week Low10.24
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)0.22
PE51.5
Fwd PEN/A
Earnings (Next)11-03 2025-11-03
IPO2024-01-22
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


AFJK short term performance overview.The bars show the price performance of AFJK in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 1 2 3 4 5

AFJK long term performance overview.The bars show the price performance of AFJK in the last 1, 2 and 3 years. 1 year 2 years 3 years 2 4 6 8

The current stock price of AFJK is 11.33 USD. In the past month the price increased by 0.35%. In the past year, price increased by 8.94%.

AIMEI HEALTH TECHNOLOGY CO / AFJK Daily stock chart

AFJK Latest News, Press Relases and Analysis

About AFJK

Company Profile

AFJK logo image Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company is headquartered in New York City, New York. The company went IPO on 2024-01-22. The firm is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The firm do not have any specific business combination under consideration and has not nor has anyone on behalf, directly or indirectly, contacted any prospective target business. The company has not generated any revenues.

Company Info

AIMEI HEALTH TECHNOLOGY CO

10 East 53rd Street, Suite 3001

New York City NEW YORK US

Employees: 0

Phone: 134678035200

AIMEI HEALTH TECHNOLOGY CO / AFJK FAQ

What does AFJK do?

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company is headquartered in New York City, New York. The company went IPO on 2024-01-22. The firm is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The firm do not have any specific business combination under consideration and has not nor has anyone on behalf, directly or indirectly, contacted any prospective target business. The company has not generated any revenues.


What is the stock price of AIMEI HEALTH TECHNOLOGY CO today?

The current stock price of AFJK is 11.33 USD. The price decreased by -0.61% in the last trading session.


Does AIMEI HEALTH TECHNOLOGY CO pay dividends?

AFJK does not pay a dividend.


What is the ChartMill rating of AIMEI HEALTH TECHNOLOGY CO stock?

AFJK has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


What is the market capitalization of AFJK stock?

AIMEI HEALTH TECHNOLOGY CO (AFJK) has a market capitalization of 69.34M USD. This makes AFJK a Micro Cap stock.


Who owns AIMEI HEALTH TECHNOLOGY CO?

You can find the ownership structure of AIMEI HEALTH TECHNOLOGY CO (AFJK) on the Ownership tab.


AFJK Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to AFJK. When comparing the yearly performance of all stocks, AFJK turns out to be only a medium performer in the overall market: it outperformed 54.75% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

AFJK Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to AFJK. AFJK has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AFJK Financial Highlights

Over the last trailing twelve months AFJK reported a non-GAAP Earnings per Share(EPS) of 0.22. The EPS increased by 1388.42% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA 4.03%
ROE 4.31%
Debt/Equity 0.03
Chartmill High Growth Momentum
EPS Q2Q%-0.86%
Sales Q2Q%N/A
EPS 1Y (TTM)1388.42%
Revenue 1Y (TTM)N/A

AFJK Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

AFJK Ownership

Ownership
Inst Owners66.97%
Ins Owners2.48%
Short Float %0%
Short Ratio0.01